Dishman Pharma(Amalg Latest News

  1. This resulted in the renewal of the GMP-certificates, granted for its all three sites situated at - Bubendorf, Aarau and Neuland
    Date:24-07-2017
  2. Dishman Pharmaceuticals & Chemicals has informed that the meeting of the Management Committee of Board of Directors of amalgamated entity i.e. Dishman Carbogen Amcis Limited (DCAL) [formerly known as Carbogen Amcis (Ind...

    Date:17-05-2017
  3. Dishman Pharmaceuticals and Chemicals has submitted the Shareholding Pattern for the Period Ended March 31, 2017.

    The above information is a part of company’s filings submitted to BSE....

    Date:20-04-2017
  4. The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhadra Raj Holdings.

    The above information is a part of...

    Date:04-04-2017
  5. The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhadra Raj Holdings.

    The above information is a part of...

    Date:04-04-2017
  6. The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals on March 28, 2017, with reference to the news flashed on CNBC TV18 dated March 28, 2017 quoting ‘US FDA Approves Zejula Capsules’.<...

    Date:28-03-2017
  7. The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Janmejay R Vyas.

    The above information is a part of company’s filin...

    Date:16-03-2017
  8. Total income of the company decreased by 3.39% at Rs 377.60 crore for the quarter under review
    Date:14-02-2017
  9. The company’s facilities in Bavla, Naroda and Switzerland continue to be approved by the USFDA
    Date:02-02-2017
  10. The company’s facilities in Bavla, Naroda and Switzerland continue to be approved by the USFDA
    Date:02-02-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
 
 
Request a Call Back
Mobile
Invalid Mobile Number
x
Thanks. We will call you shortly.